Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of Real Life Treatment for Multiple Myeloma (MM)
ClinicalTrials.gov study NCT04985643. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)
ClinicalTrials.gov study NCT03875495. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT00445692. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma
ClinicalTrials.gov study NCT00792142. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
ClinicalTrials.gov study NCT03958656. IPD Sharing: NO. Countries: 1. Publications: 0.
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
ClinicalTrials.gov study NCT05090566. IPD Sharing: YES. Countries: 2. Publications: 0.
Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01062230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
ClinicalTrials.gov study NCT01965834. IPD Sharing: NO. Countries: 1. Publications: 0.
Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).
ClinicalTrials.gov study NCT00741780. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
ClinicalTrials.gov study NCT06055894. IPD Sharing: YES. Countries: 1. Publications: 0.
Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
ClinicalTrials.gov study NCT00135200. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03256045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06669247. IPD Sharing: YES. Countries: 2. Publications: 0.
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
ClinicalTrials.gov study NCT06980480. IPD Sharing: YES. Countries: 2. Publications: 0.
Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients
ClinicalTrials.gov study NCT07253103. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00054353. IPD Sharing: Not stated. Countries: 2. Publications: 0.
RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma
ClinicalTrials.gov study NCT07114432. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01849848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
ClinicalTrials.gov study NCT06976476. IPD Sharing: YES. Countries: 1. Publications: 0.
Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00619684. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.